WICHITA SOCIETY OF NEUROSCIENCE
September 13, 2000
AGENDA & MINUTES
Attending: R. Hassan, MD, L. Klafta, MD, J. Hered, MD,
T. Kryzer, MD, C. Ruthven, PhD
Dr. Joe Ma has resigned the position of Secretary/Treasurer. Dr. Hassan has asked Dr. Hana Razek to fill this position if Board approves. The Board approved the appointment.
2. General membership drive/life membership
3. Web page/Membership directory
It was agreed that a Web page is definitely needed for the Society of Neuroscience. Since Dr. Ma and Dr. Massey were looking into getting something set up with the KU Med School, Dr. Kryzer offered to check with Dr. Massey to find out if anyth ing had been done. Dr. Courtney Ruthven agreed to check with the PMHM webmaster to find out if she would be interested in setting up a WSN web page. Dr. Ruthven did state that we would have to find someone to take care of the maintenance for a web page. Dr. Kryzer and Dr. Ruthven will report back. Question was asked if the Neuroscience National Organization has any Web page that we could be linked up to?
Discussion was held on improving the attendance of the Tuesday morning conferences. Comments were made that Dr. Massey has done an excellent job. Clinical cases are very interesting and maybe should cover a wider range of medical problems. Dr. H ered would like to see the neuro-surgeons discuss interesting cases.
Discussion was held about the evening dinner lectures. It was requested that there not be so much new medication talked about and more about; a) what’s new in neuroscience, b) new procedures, in other words a wider range of material.
It was decided that a social night only be set up for the Annual Meeting to be held the latter part of October or first part of November at the Olive Tree or Marriott.
Dr. Hassan asked the Board if they would like to hold a CME Conference this year. It was agreed to have a conference so a topic and a speaker will need to be found. It was discussed if it should be sponsored by the Society alone or along with a p harmaceutical company. It was requested that if a pharmaceutical company was involved that we not have so much discussion about medications but more of a wider range concerning new procedures or more about what is new in neuroscience. So Dr. Hassan will check into this conference.
Respectfully submitted,